Feb 4 (Reuters) - AbbVie forecast 2026 profit above ‌Wall ​Street estimates on Wednesday ‌after posting a fourth-quarter results beat, fueled by strong demand ​for newer immunology drugs Skyrizi and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results